GlassScriptPhysician profile
Eric Irving Finkelstein
NPI 1821050931
$37,277.51
in general payments reported to CMS, 2019-2025
53 companies · $4,983 in 2025
The $4,983 reported for 2025 was more than what 94% of Pain Medicine (Physical Medicine & Rehabilitation) providers received nationally (typical 2025 total: $400).
See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,114 · 2020: $1,497 · 2021: $3,398 · 2022: $2,925 · 2023: $8,176 · 2024: $14K · 2025: $4,983.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $19K · Food and Beverage: $6,151 · Travel and Lodging: $2,129 · Education: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $18,562.50 |
| Food and Beverage | $6,151.26 |
| Travel and Lodging | $2,129.35 |
| Education | $500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spinal Simplicity, LLC | $14,274.48 | 2022-2025 | Ha Minuteman G3-R |
| Saluda Medical Americas, INC. | $8,997.71 | 2023-2025 | Evoke, Evoke Scs |
| Abbott Laboratories | $2,234.58 | 2019-2025 | Proclaim, Eterna |
| Mml US, INC. | $2,143.54 | 2021-2023 | Reactiv8 |
| Nevro Corp. | $2,115.98 | 2019-2023 | Senza |
| Boston Scientific Corporation | $1,265.64 | 2019-2025 | Wavewriter Alpha Prime 16, Infinion 16, Intracept |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $978.09 | 2019-2025 | Relistor |
| Abbvie INC. | $938.31 | 2021-2024 | |
| Vertos Medical, INC. | $580.25 | 2021-2023 | Mild Device Kit |
| Collegium Pharmaceutical, INC. | $578.41 | 2019-2025 | Xtampza, Belbuca |
| Medtronic, INC. | $495.90 | 2021-2025 | Vanta Adaptivestim, Intellis Adaptivestim, Accurian |
| Biotronik Nro, INC. | $463.40 | 2023-2025 | Prospera, Biotronik |
| Pfizer INC. | $276.48 | 2019-2025 | |
| Amgen INC. | $193.76 | 2019-2022 | |
| Scilex Pharmaceuticals INC. | $132.49 | 2019-2021 |
Show all 53 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Finkelstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.